(HealthDay)—A gene expression signature can identify T-cell mediated rejection (TCMR) ahead of time in kidney transplant recipients, according to a study published online March 1 in EBioMedicine.
Mar 6, 2019
0
7
Patients with glioblastoma have very poor prognosis since there are no effective therapies. In a study published in Cell Reports, researchers at Uppsala University have discovered a correlation between the cell type from ...
Jan 24, 2017
0
0
University of North Carolina Lineberger Comprehensive Cancer Center researchers and collaborators are working to predict, before treatment, whether an aggressive type of breast cancer will respond to chemotherapy.
Dec 8, 2016
0
0
Researchers have discovered a gene signature in healthy brains that echoes the pattern in which Alzheimer's disease spreads through the brain much later in life. The findings, published in the journal Science Advances, could ...
Aug 10, 2016
0
5
A team of immunologists and informatics experts at the Stanford University School of Medicine has identified a distinctive pattern of gene expression that distinguishes people with a viral infection from those with a bacterial ...
Dec 15, 2015
0
6
It may seem incredulous, but breast tumors may have something in common with embryos ... at least in mice, say researchers at The University of Texas MD Anderson Cancer Center.
Jun 30, 2015
0
12
Cancer researchers at Indiana University report that about 15 percent of people with pancreatic cancer may benefit from therapy targeting a newly identified gene signature.
Feb 26, 2015
0
8
By looking at the expression levels of downstream genes of the regulators in breast cancer, investigators at Dartmouth Hitchcock's Norris Cotton Cancer Center (NCCC), led by Chao Cheng, PhD, have identified a gene signature ...
Jan 7, 2015
0
11
A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.
Oct 23, 2014
0
0
(HealthDay)—For patients with node-negative breast cancer (NNBC), the 70-gene signature is unlikely to be cost-effective for guiding adjuvant chemotherapy decision making, according to a study published online Oct. 6 in ...
Oct 18, 2014
0
0
